MDA Venture Philanthropy

About The Fund

MDA Venture Philanthropy (MVP) is a strategic drug development program initiated by the Muscular Dystrophy Association, dedicated to financing and accelerating the discovery and clinical application of treatments and cures for neuromuscular diseases. MVP is focused on bio-tech and life science industries, particularly in areas like oncology that can intersect with the treatment of neuromuscular conditions. Implementing a venture capital approach, the program seeks measurable results in its investments and works closely with a network of scientific and industry advisors to achieve its goals. MVP evaluates investment opportunities in both non-profit and for-profit organizations, as well as academic institutions developing therapeutics. The Muscular Dystrophy Association, behind MVP, centers their cause on empowering individuals with neuromuscular diseases to lead fuller, more independent lives. They are deeply involved in advancing research, improving care, and fostering advocacy, with 75 years of experience in the field. The MDA's impact is evidenced by its contributions to genetic research, care advances, and treatment development. They offer comprehensive care and resources and strive to redefine living with neuromuscular diseases. Their support network includes community education, MDA care centers, and a range of fund-raising and volunteering initiatives designed to involve the larger community in their mission. MDA Venture Philanthropy is part of a larger effort to drive scientific breakthroughs and deliver real-world treatments that offer hope and improvement for those affected by neuromuscular conditions.